Dimitra Zagoura

Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells.

In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells.

Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.

Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure.

Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.

Regenerative toxicology: the role of stem cells in the development of chronic toxicities.

Sox2 suppression by miR-21 governs human mesenchymal stem cell properties.

Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: effects of CREB pathway inhibition.

A comparative transcriptomic study on the effects of valproic acid on two different hESCs lines in a neural teratogenicity test system.

Role of environmental chemicals, processed food derivatives, and nutrients in the induction of carcinogenesis.

Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells.

miR-26a Mediates Adipogenesis of Amniotic Fluid Mesenchymal Stem/Stromal Cells via PTEN, Cyclin E1, and CDK6.